FDA gives Merck ‘real-time’ OK for Keytruda, offering a peek at the latest extension of the agency's data express highway
The FDA doesn’t always wait for a marketing application to come in before it begins its review these days. And that suits Merck just fine …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.